SDF2L1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.845800000013E-06 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.580070E-03 |
Normal-vs-Stage2 |
3.183700E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.732350E-02 |
Stage1-vs-Stage2 |
9.397200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.494600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.151600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.14039999999471E-05 |
Normal-vs-AfricanAmerican |
6.119600E-01 |
Normal-vs-Asian |
2.587200E-01 |
Caucasian-vs-AfricanAmerican |
4.356400E-01 |
Caucasian-vs-Asian |
8.179600E-01 |
AfricanAmerican-vs-Asian |
6.078000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.629830E-04 |
Normal-vs-Female |
6.418500E-03 |
Male-vs-Female |
1.751810E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.580700E-03 |
Normal-vs-Extreme_Weight |
5.017900E-03 |
Normal-vs-Obese |
3.817900E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.533600E-01 |
Normal_Weight-vs-Obese |
8.351800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.587600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.950000E-01 |
Normal-vs-Age(41-60Yrs) |
6.520300E-02 |
Normal-vs-Age(61-80Yrs) |
3.37709999997937E-06 |
Normal-vs-Age(81-100Yrs) |
2.937400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.878100E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.848000E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.052000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.596800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.620360E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.860300E-02 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.623100E-03 |
Normal-vs-Grade 3 |
2.498500E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.467200E-01 |
Grade 2-vs-Grade 4 |
7.623100E-03 |
Grade 3-vs-Grade 4 |
2.498500E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.438100E-04 |
Normal-vs-N1 |
4.245500E-02 |
N0-vs-N1 |
9.549200E-01 |
|
|